![](https://investorshub.advfn.com/uicon/65235.png?cb=1464375070)
Wednesday, December 05, 2007 8:04:14 PM
Net sales and rental income 2007 2006 2005 2004
Q1 $1,336,731.00 $505,091.00 $544,943.00 $262,941.00
Q2 $1,505,207.00 $560,860.00 $589,483.00 $336,705.00
Q3 $2,104,446.00 $743,787.00 $604,141.00 $366,784.00
Q4 $747,071.00 $359,841.00 $290,246.00
I think there is likely an added lag in the billing cycle too so the Q4 numbers may not quite match up with peoples expectations.
I agree with 10bagger and some may have felt they missed the boat and are looking to criticize the stock. There is no (negative) surprise here. Am I disappointed orders weren't hirer? Yes. Does this mean the growth has stopped or the company is overvalued? Not by any means in my book! I haven't sold and personally am not too upset with our low PE as it makes it easy to hold on to the shares as I can't imagine selling anytime soon! Granted we're a microcap and won't get as high PE of a company growing in triple digits but as someone pointed out our forward PE given our growth rate is unbelievable (low).
I generally like to buy early on and hold for the long term but if the Q4 isn't up to peoples expectations it may present a unique opportunity as history would indicate Q1 tends to pickup and then increase throughout the year [even before the sales force ramp].
As the company grows Sandgaard gets a lot more options open to him/the company. More products, partnering, better name/brand recognition, bigger exchange listing, etc.
Recent ZYXI News
- Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 • PR Newswire (US) • 06/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:24:18 PM
- Zynex to Present at the RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/09/2024 01:15:00 PM
- Zynex Executives Recognized Among Top 25 in Medical Technology • PR Newswire (US) • 05/07/2024 01:15:00 PM
- Zynex Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:01:00 PM
- Zynex Sets First Quarter 2024 Earnings Call • PR Newswire (US) • 04/18/2024 01:15:00 PM
- Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award • PR Newswire (US) • 04/02/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:15:17 PM
- Zynex Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:01:00 PM
- Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call • PR Newswire (US) • 02/22/2024 02:15:00 PM
- Zynex Introduces New Products • PR Newswire (US) • 02/20/2024 02:15:00 PM
- Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 • GlobeNewswire Inc. • 02/08/2024 02:00:00 PM
- Zynex Receives FDA Clearance for its Next Generation NMES Device • PR Newswire (US) • 02/06/2024 02:15:00 PM
- Zynex Recognized in Top 25 Medical Device Companies for 2024 • PR Newswire (US) • 02/02/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 10:55:32 PM
- Zynex to Participate at the Needham Annual Growth Conference • PR Newswire (US) • 01/08/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:15:06 PM
- Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024" • PR Newswire (US) • 11/15/2023 02:15:00 PM
- Zynex Submits FDA Application for its Next Generation NMES Device • PR Newswire (US) • 11/13/2023 02:15:00 PM
- Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year • PR Newswire (US) • 11/09/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:20:20 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM